A groundbreaking study reveals that insulin resistance, measured by the triglyceride-glucose (TyG) index, can be a crucial indicator of rapid cognitive decline in Alzheimer's patients. Those with higher TyG levels face a fourfold increase in deterioration rates, prompting new intervention strategies.
A groundbreaking study reveals that a blood test can identify Alzheimer's patients at risk of rapid decline. Researchers highlight the importance of insulin resistance in accelerating cognitive impairment, opening doors for timely interventions.
A new study reveals that engaging with digital technology may significantly reduce the risk of cognitive impairment among middle-aged and older adults. Discover how smartphones and tablets might help preserve brain function!
Recent research suggests that Ozempic and similar GLP-1 drugs may lower the risk of dementia in those with type 2 diabetes. Discover how these drugs are being tested for dementia prevention!
New research reveals that poor sleep quality, specifically reduced slow wave and REM sleep, is linked to smaller brain volumes in Alzheimer’s disease-vulnerable areas. This underscores the importance of restorative sleep for long-term brain health.
A groundbreaking blood test developed by researchers may change how Alzheimer's is diagnosed and treated, providing insights into the disease's progression and helping identify suitable medications.
New research reveals that certain antidepressants may worsen cognitive decline in patients with dementia. Find out which drugs are linked to faster decline and how this study could impact future treatment decisions.
